RZ358
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RZ358, covering 2025-05-28 to 2026-01-08. Get the full timeline:
Most recent: Clinical Trial Update: RZ358 Treatment for Congenital Hyperinsulinism [Phase 3]